PTGES and neoplasm: In conclusion, our data demonstrate that the human mPGES-1 inhibitor, AF3485, exerts antitumor activity which appears, in this epithelial tumor model, to be related to inhibition of EGFR signaling and to an effect on tumor microvessel growth.